Literature DB >> 4062562

Protein synthesis in cells infected by chilo iridescent virus (iridovirus, type 6).

S Barray, G Devauchelle.   

Abstract

Synthesis of the polypeptides induced in CIV-infected cells was studied using radiolabelled methionine in a permissive cell line of Choristoneura fumiferana. Analysis of labelled cell extracts by high resolution polyacrylamide gel electrophoresis (PAGE) revealed the sequential appearance of at least 28 structural and non-structural polypeptides in permissive conditions. This was confirmed by analysis of protein synthesis in non-permissive cell lines of Lymantria dispar, Aedes albopictus or by the use of protein, RNA and DNA synthesis inhibitors in the permissive cell line.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4062562     DOI： 10.1007/BF01309835

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  10 in total

1.  Enzyme activities associated with an invertebrate iridovirus: nucleotide phosphohydrolase activity associated with iridescent virus type 6 (CIV).

Authors:  C Monnier; G Devauchelle
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

2.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

3.  Macromolecular synthesis in cells infected by frog virus 3. I. Virus-specific protein synthesis and its regulation.

Authors:  R Goorha; A Granoff
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  [Replication of type 6 ridovirus in various cell lines].

Authors:  M Cerutti; J Guérillon; M Arella; G Devauchelle
Journal:  C R Seances Acad Sci III       Date:  1981-03-30

6.  Serological relationships of an iridescent virus (type 25) recently isolated from Tipula sp. with two other iridescent viruses (types 2 and 22).

Authors:  R M Elliott; T Lescott; D C Kelly
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

7.  Effects of arabinofuranosylthymine on Epstein-Barr virus replication.

Authors:  T Ooka; A Calender
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

8.  Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides.

Authors:  T H Pennington
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

9.  Frog virus 3 replication: induction and intracellular distribution of polypeptides in infected cells.

Authors:  R M Elliott; D C Kelly
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  [Study of the structural polypeptides of Chilo suppressalis iridescent virus (Iridovirus type 6)].

Authors:  S Barray; G DeVauchelle
Journal:  Can J Microbiol       Date:  1979-07       Impact factor: 2.419
  10 in total
  4 in total

1.  Identification of viral antigenic determinants by monoclonal antibodies directed against Chilo iridescent virus (iridovirus type 6). Brief report.

Authors:  N Orange; J Guerillon; G Devauchelle
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Isolation of polysomes from permissive and non-permissive invertebrate cell lines infected with chilo iridescent virus.

Authors:  F Petit; G Devauchelle
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

Review 3.  Invertebrate Iridoviruses: A Glance over the Last Decade.

Authors:  İkbal Agah İnce; Orhan Özcan; Ayca Zeynep Ilter-Akulke; Erin D Scully; Arzu Özgen
Journal:  Viruses       Date:  2018-03-30       Impact factor: 5.048

4.  Proteomic analysis of Chilo iridescent virus.

Authors:  Ikbal Agah Ince; Sjef A Boeren; Monique M van Oers; Jacques J M Vervoort; Just M Vlak
Journal:  Virology       Date:  2010-07-02       Impact factor: 3.616
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.